The publisher observes that the shift to drug-eluting stents and drug-coated balloons will be the key trends driving the peripheral vascular devices industry during the forecast period. Investments in bioresorbable scaffolds will further drive the market growth. Drug-eluting bioresorbable scaffolds are an area of interest among industry stakeholders. Moreover, interest in developing innovative solutions for peripheral artery disease, especially below-the-knee peripheral artery disease and complex chronic limb-threatening ischemia, positively impacts the market growth.Innovations in Drug-eluting Stents and Drug-coated Balloons are Driving Transformational Growth
This study analyzes peripheral vascular devices, such as metal stents, bioresorbable stents, drug-eluting stents, drug-coated balloons, percutaneous transluminal angioplasty (PTA) balloons, and catheters. Regional coverage includes North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The study provides insights into industry size, growth rates, growth opportunities, strategic imperatives, patient pathways, company market share, procedure trends, new technologies, and end users.
The study period is from 2021 to 2029, the base year is 2024, and the forecast period is from 2024 to 2029.
Table of Contents
Research Scope
Growth Environment: Transformation in the Peripheral Vascular Devices Industry
Ecosystem in the Peripheral Vascular Devices Industry
Growth Generator in the Peripheral Vascular Devices Industry
Growth Generator: North America
Growth Generator: Europe
Growth Generator: Asia-Pacific
Growth Generator: Latin America
Growth Generator: Middle East and Africa
Growth Opportunity Universe in the Peripheral Vascular Devices Industry
Appendix & Next Steps
